NQO1‐Responsive Prodrug for in Cellulo Release of Cytochalasin B as Cancer Cell‐Targeted Migrastatic
Open Access
Abstract
Migrastatic drugs targeting cell motility and suppressing invasiveness of solid tumors, have the potential to bring about a paradigm shift in the treatment of solid cancer. Cytochalasin B ( CB ) is a potent migrastatic compound, but its clinical use is limited by poor selectivity. Here, a NQO1‐responsive prodrug, BQTML‐CB is developed, synthesized in three steps from cytochalasin B derived from Preussia similis G22. BQTML‐CB is selectively activated in NQO1‐positive cancer cells, releasing active CB . In vitro , BQTML‐CB significantly inhibits proliferation and migration in NQO1‐positive U‐2OS cells, causing actin disruption and cytokinesis abnormalities, while sparing NQO1‐negative B16‐F1 cells. The prodrug shows reduced effects on human neutrophils, indicating reduced immunosuppressive activity of BQTML‐CB compared to CB . Co‐culture studies reveal a beneficial bystander effect, as cleaved CB diffused into adjacent NQO1‐deficient cells. These findings support BQTML‐CB as a cancer‐targeted prodrug with selective antiproliferative and migrastatic properties, highlighting the potential of C7‐OH‐modified cytochalasans in cancer therapy.Keywords
All Related Versions
Funding Information
- Stiftelsen Konung Gustaf V:s 80-årsfond
- Vetenskapsrådet (2022‐00561)
- Deutsche Forschungsgemeinschaft (KL3012/4‐1)
- Deutsche Forschungsgemeinschaft (RO2414/12‐1)
- Deutsche Forschungsgemeinschaft (STA1282/8‐1)
- Deutsche Forschungsgemeinschaft (STR 666/10‐1)
- Göteborgs Universitet
This publication has 102 references indexed in Scilit:
- Diversely Functionalised Cytochalasins through Mutasynthesis and Semi‐SynthesisChemistry – A European Journal, 2020
- Small‐Molecule Inhibition of Glucose Transporters GLUT‐1–4ChemBioChem, 2019
- Are 90% of deaths from cancer caused by metastases?Cancer Medicine, 2019
- Biomimetic Synthesis of (+)‐Aspergillin PZAngewandte Chemie International Edition, 2018
- Multifaceted Study on a Cytochalasin Scaffold: Lessons on Reactivity, Multidentate Catalysis, and Anticancer PropertiesChemistry – A European Journal, 2018
- Trimethyl Lock: A Multifunctional Molecular Tool for Drug Delivery, Cellular Imaging, and Stimuli‐Responsive MaterialsChemBioChem, 2018
- First Total Synthesis, Structure Revision, and Natural History of the Smallest Cytochalasin: (+)‐Periconiasin GChemistry – A European Journal, 2016
- Total Syntheses of Periconiasins A–EAngewandte Chemie, 2016
- Actin‐Binding Marine Macrolides: Total Synthesis and Biological ImportanceAngewandte Chemie International Edition, 2002
- The Cytochalasans: A New Class of Biologically Active Microbial MetabolitesAngewandte Chemie International Edition, 1973